SlideShare a Scribd company logo

Dedication-Clemmensen

•Download as PPT, PDF•
•
TriMed Media Group
TriMed Media Group
Health & Medicine
1 of 26
Peter Clemmensen, Henning Kelbæk, Anne Kaltoft, Steffen Helqvist, Jens Flensted Lassen, Lene Kløvgaard, Christian J Terkelsen, Hans Henrik Tilsted, Thomas Engstrøm, Lars R Krusell, Evald H. Christiansen, Kari Saunamäki, Erik Jørgensen, Hans E. Bøtker, Jan Ravkilde, Klaus F Kofoed, Lars Køber, Leif Thuesen Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-elevation myocardial infarction 3 year follow-up of the randomised DEDICATION trial Copenhagen University Hospital Rigshospitalet Aarhus University Hospital Skejby Denmark
[object Object],[object Object],[object Object],Disclosures
[object Object],Background
Drug-Eluting vs Bare-Metal Stent Implantation during Primary PCI Previous published studies with ≥ 150 patients Study STRATEGY TYPHOON PASSION SESAMI n 175 712 619 320 FU 133 170 - 166 DES/BMS 18/32 7/14 9/13 7/17 DES/BMS 8/28 7/20 - 9/21 endpoint MACCE TVF MACE RS p 0.001 0.004 0.09 0.03 Invasive Primary RS,% MACE,%
[object Object],[object Object],Purpose
STEMI n=626 Randomization + Distal Protection - Distal Protection Bare Metal Stent MACE Angiography - QCA / MACE 1 month 15 months Bare Metal Stent Drug Eluting Stent Drug Eluting Stent Flow chart Post Procedure Angiography - QCA MACE MACE 8 months 3 years
STEMI n=626 Randomization + Distal Protection - Distal Protection Bare Metal Stent MACE Angiography - QCA / MACE 1 month 15 months Bare Metal Stent Drug Eluting Stent Drug Eluting Stent Flow chart Post Procedure Angiography - QCA MACE MACE 8 months 3 years
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Endpoints
Major inclusion criteria ,[object Object],[object Object],[object Object],[object Object],[object Object]
Major exclusion criteria ,[object Object],[object Object],[object Object],[object Object],[object Object]
Screened patients 1687 Included patients 626 Excluded patients 1061 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],24 deaths 83 lost to re-angiography Study Flow 543 patients for re-angiography 602 patients for 8-month FU 573 patients for 3-year FU 29 deaths
STEMI - PPCI n: 626 Randomization Drug Eluting Stent n: 313 Bare Metal Stent n: 313 Number of Patients
Baseline clinical characteristics DES n=313 BMS n=313 p 0.41 0.93 0.30 0.67 0.54 0.88 0.87 0.45 0.20 0.56 0.69 0.63 63 73.5 11.5 34.0 21.4 54.7 38.2 0.47 7.1 5.4 200 25 62 72.8 9.3 32.3 18.7 52.7 37.3 0.48 6.1 4.5 197 25 Age (years) Male gender (%) Diabetes Mellitus (%) Hypertension (%) Hyperlipidemia (%) Current smoker (%) Family history of CAD (%) Left ventricular ejection fraction Previous myocardial infarction (%) Previous PCI / CABG (%) Symptom onset to arrival, min Door-to-balloon, min
Baseline lesion characteristics 0.27 DES n=313 BMS n=313 p 0.57 0.47 38 14 48 61 29 10 70 30 44 11 45 65 25 10 65 35 Infarct related coronary artery (%) LAD CX RCA Number of diseased vessel (%) 1 vessel disease 2 vessel disease 3 vessel disease Baseline TIMI flow TIMI 0-1 TIMI 2-3
Procedural results DES n=313 BMS n=313 p 0.21 0.33 0.38 0.29 0.52 0.13 0.86 0.20 1.00 0.73 95 72 42 98 1.3 21.0 3.53 16.3 90 99 97 74 40 99 1.3 22.2 3.54 16.7 90 98 Use of GP IIb/IIIa inhibitor, % Visible thrombus,% Filterwire used, % Stent implanted, % Number of stents per lesion Stented length, mm Stent diameter, mm Max deployment pressure, mm Hg TIMI III post procedure Procedural success, %
P=0.084 P=0.013 P=0.58 P=0.45 P<0.001 P<0.001 P=0.64 P=0.024 MACE during 3 years
0 200 400 600 800 1000 1200 P=0.028 DES BMS 100 80 60 40 Freedom from MACE Freedom from MACE Days
0 200 400 600 800 1000 1200 P=0.059 DES BMS 100 80 60 40 Freedom from all-cause mortality (%) Freedom from all-cause mortality Days
0 200 400 600 800 1000 1200 P=0.008 DES BMS 100 80 60 40 Freedom from cardiac mortality (%) Freedom from cardiac mortality Days
10 8 6 4 2 0 P=0.511 DES BMS Cumulative incidence (%) 0 200 400 600 800 1000 1200 Any stent thrombosis Days
10 8 6 4 2 0 P=0.296 DES BMS Cumulative incidence (%) 0 200 400 600 800 1000 1200 Definite stent thrombosis Days
0 0.5 1.0 0.5 2.0 no DM 561 11.3 17.7 DM 65 13.8 22.2 Female 168 10.6 24.1 Male 458 11.8 16.1 Age  63 311 13.7 17.1 Age < 63 315 9.4 19.4 All 626 11.5 18.2 Group n DES BMS DES better BMS better Odds Ratio (95% CI) Rate of MACE (%) Subgroup analysis CX / RCA 368 9.4 16.4 LAD 258 14.8 20.6 Stent length  18 mm 310 9.5 17.9 Stent length > 18 mm 309 12.9 17.8 No visible thrombus 168 11.1 24.1 Visible thrombus 458 11.6 15.9 Ref D  3.1 mm 299 12.0 20.8 Ref D > 3.1 mm 317 9.6 15.6
0 0.5 1.0 0.5 2.0 no DM 561 11.3 17.7 DM 65 13.8 22.2 Female 168 10.6 24.1 Male 458 11.8 16.1 Age  63 311 13.7 17.1 Age < 63 315 9.4 19.4 All 626 11.5 18.2 Group n DES BMS DES better BMS better Odds Ratio (95% CI) Rate of MACE (%) Subgroup analysis CX / RCA 368 9.4 16.4 LAD 258 14.8 20.6 Stent length  18 mm 310 9.5 17.9 Stent length > 18 mm 309 12.9 17.8 No visible thrombus 168 11.1 24.1 Visible thrombus 458 11.6 15.9 Ref D  3.1 mm 299 12.0 20.8 Ref D > 3.1 mm 317 9.6 15.6
0 0.5 1.0 0.5 2.0 no DM 561 11.3 17.7 DM 65 13.8 22.2 Female 168 10.6 24.1 Male 458 11.8 16.1 Age  63 311 13.7 17.1 Age < 63 315 9.4 19.4 All 626 11.5 18.2 Group n DES BMS DES better BMS better Odds Ratio (95% CI) Rate of MACE (%) Subgroup analysis CX / RCA 368 9.4 16.4 LAD 258 14.8 20.6 Stent length  18 mm 310 9.5 17.9 Stent length > 18 mm 309 12.9 17.8 No visible thrombus 168 11.1 24.1 Visible thrombus 458 11.6 15.9 Ref D  3.1 mm 299 12.0 20.8 Ref D > 3.1 mm 317 9.6 15.6
0 0.5 1.0 0.5 2.0 no DM 561 11.3 17.7 DM 65 13.8 22.2 Female 168 10.6 24.1 Male 458 11.8 16.1 Age  63 311 13.7 17.1 Age < 63 315 9.4 19.4 All 626 11.5 18.2 Group n DES BMS DES better BMS better Odds Ratio (95% CI) Rate of MACE (%) Subgroup analysis CX / RCA 368 9.4 16.4 LAD 258 14.8 20.6 Stent length  18 mm 310 9.5 17.9 Stent length > 18 mm 309 12.9 17.8 No visible thrombus 168 11.1 24.1 Visible thrombus 458 11.6 15.9 Ref D  3.1 mm 299 12.0 20.8 Ref D > 3.1 mm 317 9.6 15.6
[object Object],Conclusions In the DEDICATION trial implantation of DES (compared with BMS) in STEMI patients ,[object Object],[object Object],[object Object]

Recommended

Cohen MG - AIMRADIAL 2013 - Complex PCI
Cohen MG - AIMRADIAL 2013 - Complex PCICohen MG - AIMRADIAL 2013 - Complex PCI
Cohen MG - AIMRADIAL 2013 - Complex PCIInternational Chair on Interventional Cardiology and Transradial Approach
 
Pori 36 Months Francophone
Pori 36 Months FrancophonePori 36 Months Francophone
Pori 36 Months Francophonebenklinger
 
Sciahbasi A - AIMRADIAL 2013 - Heparin vs bivalirudin
Sciahbasi A - AIMRADIAL 2013 - Heparin vs bivalirudinSciahbasi A - AIMRADIAL 2013 - Heparin vs bivalirudin
Sciahbasi A - AIMRADIAL 2013 - Heparin vs bivalirudinInternational Chair on Interventional Cardiology and Transradial Approach
 
Rao SV - AIMRADIAL 2013 - Bivalirudin and radial
Rao SV - AIMRADIAL 2013 - Bivalirudin and radialRao SV - AIMRADIAL 2013 - Bivalirudin and radial
Rao SV - AIMRADIAL 2013 - Bivalirudin and radialInternational Chair on Interventional Cardiology and Transradial Approach
 
Kirtane AJ - AIMRADIAL 2014 - Bivalirudin anticoagulation
Kirtane AJ - AIMRADIAL 2014 - Bivalirudin anticoagulationKirtane AJ - AIMRADIAL 2014 - Bivalirudin anticoagulation
Kirtane AJ - AIMRADIAL 2014 - Bivalirudin anticoagulationInternational Chair on Interventional Cardiology and Transradial Approach
 
Mann T 201111
Mann T 201111Mann T 201111
Mann T 201111International Chair on Interventional Cardiology and Transradial Approach
 
Bernat I - AIMRADIAL 2013 - STEMI-RADIAL trial
Bernat I - AIMRADIAL 2013 - STEMI-RADIAL trialBernat I - AIMRADIAL 2013 - STEMI-RADIAL trial
Bernat I - AIMRADIAL 2013 - STEMI-RADIAL trialInternational Chair on Interventional Cardiology and Transradial Approach
 
Scalone G - AIMRADIAL 2015 - Radial in heart transplant patients
Scalone G - AIMRADIAL 2015 - Radial in heart transplant patientsScalone G - AIMRADIAL 2015 - Radial in heart transplant patients
Scalone G - AIMRADIAL 2015 - Radial in heart transplant patientsInternational Chair on Interventional Cardiology and Transradial Approach
 

Recommended

Cohen MG - AIMRADIAL 2013 - Complex PCI
Cohen MG - AIMRADIAL 2013 - Complex PCICohen MG - AIMRADIAL 2013 - Complex PCI
Cohen MG - AIMRADIAL 2013 - Complex PCIInternational Chair on Interventional Cardiology and Transradial Approach
 
Pori 36 Months Francophone
Pori 36 Months FrancophonePori 36 Months Francophone
Pori 36 Months Francophonebenklinger
 
Sciahbasi A - AIMRADIAL 2013 - Heparin vs bivalirudin
Sciahbasi A - AIMRADIAL 2013 - Heparin vs bivalirudinSciahbasi A - AIMRADIAL 2013 - Heparin vs bivalirudin
Sciahbasi A - AIMRADIAL 2013 - Heparin vs bivalirudinInternational Chair on Interventional Cardiology and Transradial Approach
 
Rao SV - AIMRADIAL 2013 - Bivalirudin and radial
Rao SV - AIMRADIAL 2013 - Bivalirudin and radialRao SV - AIMRADIAL 2013 - Bivalirudin and radial
Rao SV - AIMRADIAL 2013 - Bivalirudin and radialInternational Chair on Interventional Cardiology and Transradial Approach
 
Kirtane AJ - AIMRADIAL 2014 - Bivalirudin anticoagulation
Kirtane AJ - AIMRADIAL 2014 - Bivalirudin anticoagulationKirtane AJ - AIMRADIAL 2014 - Bivalirudin anticoagulation
Kirtane AJ - AIMRADIAL 2014 - Bivalirudin anticoagulationInternational Chair on Interventional Cardiology and Transradial Approach
 
Mann T 201111
Mann T 201111Mann T 201111
Mann T 201111International Chair on Interventional Cardiology and Transradial Approach
 
Bernat I - AIMRADIAL 2013 - STEMI-RADIAL trial
Bernat I - AIMRADIAL 2013 - STEMI-RADIAL trialBernat I - AIMRADIAL 2013 - STEMI-RADIAL trial
Bernat I - AIMRADIAL 2013 - STEMI-RADIAL trialInternational Chair on Interventional Cardiology and Transradial Approach
 
Scalone G - AIMRADIAL 2015 - Radial in heart transplant patients
Scalone G - AIMRADIAL 2015 - Radial in heart transplant patientsScalone G - AIMRADIAL 2015 - Radial in heart transplant patients
Scalone G - AIMRADIAL 2015 - Radial in heart transplant patientsInternational Chair on Interventional Cardiology and Transradial Approach
 
Ikari Y - AIMRADIAL 2014 - Radial and IABP
Ikari Y - AIMRADIAL 2014 - Radial and IABPIkari Y - AIMRADIAL 2014 - Radial and IABP
Ikari Y - AIMRADIAL 2014 - Radial and IABPInternational Chair on Interventional Cardiology and Transradial Approach
 
CTO and LV assist devices
CTO and LV assist devicesCTO and LV assist devices
CTO and LV assist devicesEuro CTO Club
 
Kalpak O - AIMRADIAL 2014 - Total wrist access for STEMI
Kalpak O - AIMRADIAL 2014 - Total wrist access for STEMIKalpak O - AIMRADIAL 2014 - Total wrist access for STEMI
Kalpak O - AIMRADIAL 2014 - Total wrist access for STEMIInternational Chair on Interventional Cardiology and Transradial Approach
 
Long-term outcome for patients with CTOs
Long-term outcome for patients with CTOsLong-term outcome for patients with CTOs
Long-term outcome for patients with CTOsEuro CTO Club
 
Pacchioni A - AIMRADIAL 2014 - Cerebral microembolism
Pacchioni A - AIMRADIAL 2014 - Cerebral microembolismPacchioni A - AIMRADIAL 2014 - Cerebral microembolism
Pacchioni A - AIMRADIAL 2014 - Cerebral microembolismInternational Chair on Interventional Cardiology and Transradial Approach
 
Mosseri Titan Presentation For Tct 2005
Mosseri Titan Presentation For Tct 2005Mosseri Titan Presentation For Tct 2005
Mosseri Titan Presentation For Tct 2005benklinger
 
Nolan J - AIMRADIAL 2014 - Heparin is better
Nolan J - AIMRADIAL 2014 - Heparin is betterNolan J - AIMRADIAL 2014 - Heparin is better
Nolan J - AIMRADIAL 2014 - Heparin is betterInternational Chair on Interventional Cardiology and Transradial Approach
 
Rigattieri S - AIMRADIAL 2015 - Transradial and primary PCI
Rigattieri S - AIMRADIAL 2015 - Transradial and primary PCIRigattieri S - AIMRADIAL 2015 - Transradial and primary PCI
Rigattieri S - AIMRADIAL 2015 - Transradial and primary PCIInternational Chair on Interventional Cardiology and Transradial Approach
 
Verheugt F 201109
Verheugt F 201109Verheugt F 201109
Verheugt F 201109International Chair on Interventional Cardiology and Transradial Approach
 
08 Bernat aimradial20170921 Radial patency
08 Bernat aimradial20170921 Radial patency08 Bernat aimradial20170921 Radial patency
08 Bernat aimradial20170921 Radial patencyInternational Chair on Interventional Cardiology and Transradial Approach
 
Armyda 5
Armyda 5Armyda 5
Armyda 5momiamd
 
Ruzsa Z - AIMRADIAL 2013 - Carotid artery stenting
Ruzsa Z - AIMRADIAL 2013 - Carotid artery stentingRuzsa Z - AIMRADIAL 2013 - Carotid artery stenting
Ruzsa Z - AIMRADIAL 2013 - Carotid artery stentingInternational Chair on Interventional Cardiology and Transradial Approach
 
Ludwig J 20150319
Ludwig J 20150319Ludwig J 20150319
Ludwig J 20150319International Chair on Interventional Cardiology and Transradial Approach
 
Cortese B - AIMRADIAL 2014 - Acute kidney injury
Cortese B - AIMRADIAL 2014 - Acute kidney injuryCortese B - AIMRADIAL 2014 - Acute kidney injury
Cortese B - AIMRADIAL 2014 - Acute kidney injuryInternational Chair on Interventional Cardiology and Transradial Approach
 
07 FFR Kawase Y aimradial2016 - potential of pressure wire use
07 FFR Kawase Y aimradial2016 - potential of pressure wire use07 FFR Kawase Y aimradial2016 - potential of pressure wire use
07 FFR Kawase Y aimradial2016 - potential of pressure wire useInternational Chair on Interventional Cardiology and Transradial Approach
 
Hamon M_2 201111
Hamon M_2 201111Hamon M_2 201111
Hamon M_2 201111International Chair on Interventional Cardiology and Transradial Approach
 
Lancelot acs final
Lancelot acs finalLancelot acs final
Lancelot acs finalTriMed Media Group
 
Guzman L - AIMRADIAL 2014 - Radiation exposure
Guzman L - AIMRADIAL 2014 - Radiation exposureGuzman L - AIMRADIAL 2014 - Radiation exposure
Guzman L - AIMRADIAL 2014 - Radiation exposureInternational Chair on Interventional Cardiology and Transradial Approach
 
Benamer H
Benamer HBenamer H
Benamer HInternational Chair on Interventional Cardiology and Transradial Approach
 
Alaswad K 2016 CTO PCI via radial approach
Alaswad K 2016 CTO PCI via radial approachAlaswad K 2016 CTO PCI via radial approach
Alaswad K 2016 CTO PCI via radial approachInternational Chair on Interventional Cardiology and Transradial Approach
 
UPenn Oregon Telestroke
UPenn Oregon Telestroke UPenn Oregon Telestroke
UPenn Oregon Telestroke TriMed Media Group
 
PCPs speak out on rad reporting
PCPs speak out on rad reportingPCPs speak out on rad reporting
PCPs speak out on rad reportingTriMed Media Group
 

More Related Content

What's hot

CTO and LV assist devices
CTO and LV assist devicesCTO and LV assist devices
CTO and LV assist devicesEuro CTO Club
 
Long-term outcome for patients with CTOs
Long-term outcome for patients with CTOsLong-term outcome for patients with CTOs
Long-term outcome for patients with CTOsEuro CTO Club
 
Mosseri Titan Presentation For Tct 2005
Mosseri Titan Presentation For Tct 2005Mosseri Titan Presentation For Tct 2005
Mosseri Titan Presentation For Tct 2005benklinger
 
Armyda 5
Armyda 5Armyda 5
Armyda 5momiamd
 

What's hot (20)

Ikari Y - AIMRADIAL 2014 - Radial and IABP
Ikari Y - AIMRADIAL 2014 - Radial and IABPIkari Y - AIMRADIAL 2014 - Radial and IABP
Ikari Y - AIMRADIAL 2014 - Radial and IABP
 
CTO and LV assist devices
CTO and LV assist devicesCTO and LV assist devices
CTO and LV assist devices
 
Kalpak O - AIMRADIAL 2014 - Total wrist access for STEMI
Kalpak O - AIMRADIAL 2014 - Total wrist access for STEMIKalpak O - AIMRADIAL 2014 - Total wrist access for STEMI
Kalpak O - AIMRADIAL 2014 - Total wrist access for STEMI
 
Long-term outcome for patients with CTOs
Long-term outcome for patients with CTOsLong-term outcome for patients with CTOs
Long-term outcome for patients with CTOs
 
Pacchioni A - AIMRADIAL 2014 - Cerebral microembolism
Pacchioni A - AIMRADIAL 2014 - Cerebral microembolismPacchioni A - AIMRADIAL 2014 - Cerebral microembolism
Pacchioni A - AIMRADIAL 2014 - Cerebral microembolism
 
Mosseri Titan Presentation For Tct 2005
Mosseri Titan Presentation For Tct 2005Mosseri Titan Presentation For Tct 2005
Mosseri Titan Presentation For Tct 2005
 
Nolan J - AIMRADIAL 2014 - Heparin is better
Nolan J - AIMRADIAL 2014 - Heparin is betterNolan J - AIMRADIAL 2014 - Heparin is better
Nolan J - AIMRADIAL 2014 - Heparin is better
 
Rigattieri S - AIMRADIAL 2015 - Transradial and primary PCI
Rigattieri S - AIMRADIAL 2015 - Transradial and primary PCIRigattieri S - AIMRADIAL 2015 - Transradial and primary PCI
Rigattieri S - AIMRADIAL 2015 - Transradial and primary PCI
 
Verheugt F 201109
Verheugt F 201109Verheugt F 201109
Verheugt F 201109
 
08 Bernat aimradial20170921 Radial patency
08 Bernat aimradial20170921 Radial patency08 Bernat aimradial20170921 Radial patency
08 Bernat aimradial20170921 Radial patency
 
Armyda 5
Armyda 5Armyda 5
Armyda 5
 
Ruzsa Z - AIMRADIAL 2013 - Carotid artery stenting
Ruzsa Z - AIMRADIAL 2013 - Carotid artery stentingRuzsa Z - AIMRADIAL 2013 - Carotid artery stenting
Ruzsa Z - AIMRADIAL 2013 - Carotid artery stenting
 
Ludwig J 20150319
Ludwig J 20150319Ludwig J 20150319
Ludwig J 20150319
 
Cortese B - AIMRADIAL 2014 - Acute kidney injury
Cortese B - AIMRADIAL 2014 - Acute kidney injuryCortese B - AIMRADIAL 2014 - Acute kidney injury
Cortese B - AIMRADIAL 2014 - Acute kidney injury
 
07 FFR Kawase Y aimradial2016 - potential of pressure wire use
07 FFR Kawase Y aimradial2016 - potential of pressure wire use07 FFR Kawase Y aimradial2016 - potential of pressure wire use
07 FFR Kawase Y aimradial2016 - potential of pressure wire use
 
Hamon M_2 201111
Hamon M_2 201111Hamon M_2 201111
Hamon M_2 201111
 
Lancelot acs final
Lancelot acs finalLancelot acs final
Lancelot acs final
 
Guzman L - AIMRADIAL 2014 - Radiation exposure
Guzman L - AIMRADIAL 2014 - Radiation exposureGuzman L - AIMRADIAL 2014 - Radiation exposure
Guzman L - AIMRADIAL 2014 - Radiation exposure
 
Benamer H
Benamer HBenamer H
Benamer H
 
Alaswad K 2016 CTO PCI via radial approach
Alaswad K 2016 CTO PCI via radial approachAlaswad K 2016 CTO PCI via radial approach
Alaswad K 2016 CTO PCI via radial approach
 

Viewers also liked

PCPs speak out on rad reporting
PCPs speak out on rad reportingPCPs speak out on rad reporting
PCPs speak out on rad reportingTriMed Media Group
 
HCLF 2013: Evidence at the Center of Care
HCLF 2013: Evidence at the Center of CareHCLF 2013: Evidence at the Center of Care
HCLF 2013: Evidence at the Center of CareTriMed Media Group
 
Teraco Data Environments - Company Overview
Teraco Data Environments - Company OverviewTeraco Data Environments - Company Overview
Teraco Data Environments - Company OverviewTeraco Data Environments
 
Forecast of Statin Market to 2018
Forecast of Statin Market to 2018Forecast of Statin Market to 2018
Forecast of Statin Market to 2018TriMed Media Group
 
Primary Percutaneus coronary intervention
Primary Percutaneus coronary interventionPrimary Percutaneus coronary intervention
Primary Percutaneus coronary interventionRamachandra Barik
 

Viewers also liked (9)

UPenn Oregon Telestroke
UPenn Oregon Telestroke UPenn Oregon Telestroke
UPenn Oregon Telestroke
 
PCPs speak out on rad reporting
PCPs speak out on rad reportingPCPs speak out on rad reporting
PCPs speak out on rad reporting
 
HCLF 2013: Evidence at the Center of Care
HCLF 2013: Evidence at the Center of CareHCLF 2013: Evidence at the Center of Care
HCLF 2013: Evidence at the Center of Care
 
2012 CMIO Leadership Forum
2012 CMIO Leadership Forum2012 CMIO Leadership Forum
2012 CMIO Leadership Forum
 
2013 AMDIS Fall Symposium
2013 AMDIS Fall Symposium2013 AMDIS Fall Symposium
2013 AMDIS Fall Symposium
 
Primary PCI
Primary PCIPrimary PCI
Primary PCI
 
Teraco Data Environments - Company Overview
Teraco Data Environments - Company OverviewTeraco Data Environments - Company Overview
Teraco Data Environments - Company Overview
 
Forecast of Statin Market to 2018
Forecast of Statin Market to 2018Forecast of Statin Market to 2018
Forecast of Statin Market to 2018
 
Primary Percutaneus coronary intervention
Primary Percutaneus coronary interventionPrimary Percutaneus coronary intervention
Primary Percutaneus coronary intervention
 

Similar to Dedication-Clemmensen

Titax Tct 2007
Titax Tct 2007 Titax Tct 2007
Titax Tct 2007 benklinger
 
Fundación EPIC _ Is valve durability an issue?
Fundación EPIC _ Is valve durability an issue?Fundación EPIC _ Is valve durability an issue?
Fundación EPIC _ Is valve durability an issue?Fundacion EPIC
 
Angioplastia en Multiples Vasos
Angioplastia en Multiples VasosAngioplastia en Multiples Vasos
Angioplastia en Multiples VasosAscani Nicaragua
 
Friday 1653 – karmpalotis – stent patency post cto pci
Friday 1653 – karmpalotis – stent patency post cto pciFriday 1653 – karmpalotis – stent patency post cto pci
Friday 1653 – karmpalotis – stent patency post cto pciEuro CTO Club
 
Lecture Pr Windecker
Lecture Pr WindeckerLecture Pr Windecker
Lecture Pr Windeckerbenklinger
 
Intraluminal coronary thrombus aspiration in patients with STEMI. Prof. Andre...
Intraluminal coronary thrombus aspiration in patients with STEMI. Prof. Andre...Intraluminal coronary thrombus aspiration in patients with STEMI. Prof. Andre...
Intraluminal coronary thrombus aspiration in patients with STEMI. Prof. Andre...Chaichuk Sergiy
 
CTO and low ejection fraction
CTO and low ejection fraction CTO and low ejection fraction
CTO and low ejection fraction Euro CTO Club
 
Euro CTO Club – The Euro CTO trial
Euro CTO Club – The Euro CTO trialEuro CTO Club – The Euro CTO trial
Euro CTO Club – The Euro CTO trialEuro CTO Club
 
Friday 17:06 - Yamac - BVS in CTO: Angiographic and OCT follow-up data
Friday 17:06 - Yamac - BVS in CTO: Angiographic and OCT follow-up dataFriday 17:06 - Yamac - BVS in CTO: Angiographic and OCT follow-up data
Friday 17:06 - Yamac - BVS in CTO: Angiographic and OCT follow-up dataEuro CTO Club
 
Titan S.V Final Ici
Titan S.V Final IciTitan S.V Final Ici
Titan S.V Final Icibenklinger
 
16:55 Antoniucci - Stenting in CTO
16:55 Antoniucci - Stenting in CTO16:55 Antoniucci - Stenting in CTO
16:55 Antoniucci - Stenting in CTOEuro CTO Club
 
NOBLE LEFT MAIN BIFURCATION PCI.pptx
NOBLE LEFT MAIN BIFURCATION PCI.pptxNOBLE LEFT MAIN BIFURCATION PCI.pptx
NOBLE LEFT MAIN BIFURCATION PCI.pptxIrving Torres Lopez
 
CROSSVAC - A new and aggressive flossing strategy
CROSSVAC - A new and aggressive flossing strategy CROSSVAC - A new and aggressive flossing strategy
CROSSVAC - A new and aggressive flossing strategy Yamaguchi Yukihiro
 
Eluting balloons, the mechanism of action, indications for use Ivan. G. Horvath
Eluting balloons, the mechanism of action, indications for use Ivan. G. HorvathEluting balloons, the mechanism of action, indications for use Ivan. G. Horvath
Eluting balloons, the mechanism of action, indications for use Ivan. G. HorvathChaichuk Sergiy
 
Chronic Total Occlusions: The Road Less Traveled
Chronic Total Occlusions: The Road Less TraveledChronic Total Occlusions: The Road Less Traveled
Chronic Total Occlusions: The Road Less TraveledAllina Health
 
Manipal Flex Study
Manipal Flex StudyManipal Flex Study
Manipal Flex StudySMTPL
 
Friday 1745 – benamer cto and diabetes
Friday 1745 – benamer cto and diabetesFriday 1745 – benamer cto and diabetes
Friday 1745 – benamer cto and diabetesEuro CTO Club
 

Similar to Dedication-Clemmensen (20)

Titax Tct 2007
Titax Tct 2007 Titax Tct 2007
Titax Tct 2007
 
Fundación EPIC _ Is valve durability an issue?
Fundación EPIC _ Is valve durability an issue?Fundación EPIC _ Is valve durability an issue?
Fundación EPIC _ Is valve durability an issue?
 
Angioplastia en Multiples Vasos
Angioplastia en Multiples VasosAngioplastia en Multiples Vasos
Angioplastia en Multiples Vasos
 
Friday 1653 – karmpalotis – stent patency post cto pci
Friday 1653 – karmpalotis – stent patency post cto pciFriday 1653 – karmpalotis – stent patency post cto pci
Friday 1653 – karmpalotis – stent patency post cto pci
 
Lecture Pr Windecker
Lecture Pr WindeckerLecture Pr Windecker
Lecture Pr Windecker
 
Wivon
WivonWivon
Wivon
 
Intraluminal coronary thrombus aspiration in patients with STEMI. Prof. Andre...
Intraluminal coronary thrombus aspiration in patients with STEMI. Prof. Andre...Intraluminal coronary thrombus aspiration in patients with STEMI. Prof. Andre...
Intraluminal coronary thrombus aspiration in patients with STEMI. Prof. Andre...
 
CTO and low ejection fraction
CTO and low ejection fraction CTO and low ejection fraction
CTO and low ejection fraction
 
TCT 2010: COMPARE Trial
TCT 2010: COMPARE TrialTCT 2010: COMPARE Trial
TCT 2010: COMPARE Trial
 
Euro CTO Club – The Euro CTO trial
Euro CTO Club – The Euro CTO trialEuro CTO Club – The Euro CTO trial
Euro CTO Club – The Euro CTO trial
 
Montorsi P - AIMRADIAL 2015 - Carotid artery stenting
Montorsi P - AIMRADIAL 2015 - Carotid artery stentingMontorsi P - AIMRADIAL 2015 - Carotid artery stenting
Montorsi P - AIMRADIAL 2015 - Carotid artery stenting
 
Friday 17:06 - Yamac - BVS in CTO: Angiographic and OCT follow-up data
Friday 17:06 - Yamac - BVS in CTO: Angiographic and OCT follow-up dataFriday 17:06 - Yamac - BVS in CTO: Angiographic and OCT follow-up data
Friday 17:06 - Yamac - BVS in CTO: Angiographic and OCT follow-up data
 
Titan S.V Final Ici
Titan S.V Final IciTitan S.V Final Ici
Titan S.V Final Ici
 
16:55 Antoniucci - Stenting in CTO
16:55 Antoniucci - Stenting in CTO16:55 Antoniucci - Stenting in CTO
16:55 Antoniucci - Stenting in CTO
 
NOBLE LEFT MAIN BIFURCATION PCI.pptx
NOBLE LEFT MAIN BIFURCATION PCI.pptxNOBLE LEFT MAIN BIFURCATION PCI.pptx
NOBLE LEFT MAIN BIFURCATION PCI.pptx
 
CROSSVAC - A new and aggressive flossing strategy
CROSSVAC - A new and aggressive flossing strategy CROSSVAC - A new and aggressive flossing strategy
CROSSVAC - A new and aggressive flossing strategy
 
Eluting balloons, the mechanism of action, indications for use Ivan. G. Horvath
Eluting balloons, the mechanism of action, indications for use Ivan. G. HorvathEluting balloons, the mechanism of action, indications for use Ivan. G. Horvath
Eluting balloons, the mechanism of action, indications for use Ivan. G. Horvath
 
Chronic Total Occlusions: The Road Less Traveled
Chronic Total Occlusions: The Road Less TraveledChronic Total Occlusions: The Road Less Traveled
Chronic Total Occlusions: The Road Less Traveled
 
Manipal Flex Study
Manipal Flex StudyManipal Flex Study
Manipal Flex Study
 
Friday 1745 – benamer cto and diabetes
Friday 1745 – benamer cto and diabetesFriday 1745 – benamer cto and diabetes
Friday 1745 – benamer cto and diabetes
 

More from TriMed Media Group

Step up to bat and practice dictating complex cases a residents guide to effe...
Step up to bat and practice dictating complex cases a residents guide to effe...Step up to bat and practice dictating complex cases a residents guide to effe...
Step up to bat and practice dictating complex cases a residents guide to effe...TriMed Media Group
 
Radiology Workflow: Recognizing Clinical & Financial Benefits of Implementing...
Radiology Workflow: Recognizing Clinical & Financial Benefits of Implementing...Radiology Workflow: Recognizing Clinical & Financial Benefits of Implementing...
Radiology Workflow: Recognizing Clinical & Financial Benefits of Implementing...TriMed Media Group
 
Inside a Private HIE: Clinical, Economic and Operational Successes at The Was...
Inside a Private HIE: Clinical, Economic and Operational Successes at The Was...Inside a Private HIE: Clinical, Economic and Operational Successes at The Was...
Inside a Private HIE: Clinical, Economic and Operational Successes at The Was...TriMed Media Group
 
How Healthcare Reform Is Affecting Radiology, Pam Kassing
How Healthcare Reform Is Affecting Radiology, Pam KassingHow Healthcare Reform Is Affecting Radiology, Pam Kassing
How Healthcare Reform Is Affecting Radiology, Pam KassingTriMed Media Group
 
Meaningful Use: Impact on Radiology, Arun Krishnaraj
Meaningful Use: Impact on Radiology, Arun KrishnarajMeaningful Use: Impact on Radiology, Arun Krishnaraj
Meaningful Use: Impact on Radiology, Arun KrishnarajTriMed Media Group
 
CMIO Summit 2011 | Reid Coleman
CMIO Summit 2011 | Reid ColemanCMIO Summit 2011 | Reid Coleman
CMIO Summit 2011 | Reid ColemanTriMed Media Group
 
2011 CMIO Summit | Justin Graham
2011 CMIO Summit | Justin Graham2011 CMIO Summit | Justin Graham
2011 CMIO Summit | Justin GrahamTriMed Media Group
 
2011 CMIO Summit | David Cochran
2011 CMIO Summit | David Cochran2011 CMIO Summit | David Cochran
2011 CMIO Summit | David CochranTriMed Media Group
 
2011 CMIO Summit | Brian McDonough
2011 CMIO Summit | Brian McDonough2011 CMIO Summit | Brian McDonough
2011 CMIO Summit | Brian McDonoughTriMed Media Group
 
2011 CMIO Summit | Abha Agrawal
2011 CMIO Summit | Abha Agrawal2011 CMIO Summit | Abha Agrawal
2011 CMIO Summit | Abha AgrawalTriMed Media Group
 
AGFA - Dose Management for Image Quality
AGFA - Dose Management for Image QualityAGFA - Dose Management for Image Quality
AGFA - Dose Management for Image QualityTriMed Media Group
 
2011 CMIO Compensation Survey Results
2011 CMIO Compensation Survey Results2011 CMIO Compensation Survey Results
2011 CMIO Compensation Survey ResultsTriMed Media Group
 
AGFA - Dose Management for Image Quality
AGFA - Dose Management for Image QualityAGFA - Dose Management for Image Quality
AGFA - Dose Management for Image QualityTriMed Media Group
 

More from TriMed Media Group (20)

Step up to bat and practice dictating complex cases a residents guide to effe...
Step up to bat and practice dictating complex cases a residents guide to effe...Step up to bat and practice dictating complex cases a residents guide to effe...
Step up to bat and practice dictating complex cases a residents guide to effe...
 
Radiology Workflow: Recognizing Clinical & Financial Benefits of Implementing...
Radiology Workflow: Recognizing Clinical & Financial Benefits of Implementing...Radiology Workflow: Recognizing Clinical & Financial Benefits of Implementing...
Radiology Workflow: Recognizing Clinical & Financial Benefits of Implementing...
 
RSNA 2012 - Photolog
RSNA 2012 - PhotologRSNA 2012 - Photolog
RSNA 2012 - Photolog
 
201209 cit-w&inicu
201209 cit-w&inicu201209 cit-w&inicu
201209 cit-w&inicu
 
Inside a Private HIE: Clinical, Economic and Operational Successes at The Was...
Inside a Private HIE: Clinical, Economic and Operational Successes at The Was...Inside a Private HIE: Clinical, Economic and Operational Successes at The Was...
Inside a Private HIE: Clinical, Economic and Operational Successes at The Was...
 
How Healthcare Reform Is Affecting Radiology, Pam Kassing
How Healthcare Reform Is Affecting Radiology, Pam KassingHow Healthcare Reform Is Affecting Radiology, Pam Kassing
How Healthcare Reform Is Affecting Radiology, Pam Kassing
 
Meaningful Use: Impact on Radiology, Arun Krishnaraj
Meaningful Use: Impact on Radiology, Arun KrishnarajMeaningful Use: Impact on Radiology, Arun Krishnaraj
Meaningful Use: Impact on Radiology, Arun Krishnaraj
 
CMIO Summit 2011 | Reid Coleman
CMIO Summit 2011 | Reid ColemanCMIO Summit 2011 | Reid Coleman
CMIO Summit 2011 | Reid Coleman
 
2011 CMIO Summit | Justin Graham
2011 CMIO Summit | Justin Graham2011 CMIO Summit | Justin Graham
2011 CMIO Summit | Justin Graham
 
2011 CMIO Summit | Don Levick
2011 CMIO Summit | Don Levick2011 CMIO Summit | Don Levick
2011 CMIO Summit | Don Levick
 
2011 CMIO Summit | David Cochran
2011 CMIO Summit | David Cochran2011 CMIO Summit | David Cochran
2011 CMIO Summit | David Cochran
 
2011 CMIO Summit | Brian McDonough
2011 CMIO Summit | Brian McDonough2011 CMIO Summit | Brian McDonough
2011 CMIO Summit | Brian McDonough
 
2011 CMIO Summit | Ben Stein
2011 CMIO Summit | Ben Stein2011 CMIO Summit | Ben Stein
2011 CMIO Summit | Ben Stein
 
2011 CMIO Summit | Abha Agrawal
2011 CMIO Summit | Abha Agrawal2011 CMIO Summit | Abha Agrawal
2011 CMIO Summit | Abha Agrawal
 
CMIO Summit 2011 | Karen Bell
CMIO Summit 2011 | Karen BellCMIO Summit 2011 | Karen Bell
CMIO Summit 2011 | Karen Bell
 
AGFA - Dose Management for Image Quality
AGFA - Dose Management for Image QualityAGFA - Dose Management for Image Quality
AGFA - Dose Management for Image Quality
 
CMIO CHIME Survey Results
CMIO CHIME Survey ResultsCMIO CHIME Survey Results
CMIO CHIME Survey Results
 
2011 CMIO Compensation Survey Results
2011 CMIO Compensation Survey Results2011 CMIO Compensation Survey Results
2011 CMIO Compensation Survey Results
 
AGFA - Dose Management for Image Quality
AGFA - Dose Management for Image QualityAGFA - Dose Management for Image Quality
AGFA - Dose Management for Image Quality
 
CMIO | NHIN
CMIO | NHINCMIO | NHIN
CMIO | NHIN
 

Recently uploaded

Aspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliAspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliRewAs ALI
 
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomLucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomdiscovermytutordmt
 
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort ServiceCall Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Serviceparulsinha
 
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...CALL GIRLS
 
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...Neha Kaur
 
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...Call Girls in Nagpur High Profile
 
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual NeedsBangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual NeedsGfnyt
 
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...Miss joya
 
Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...
Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...
Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...Miss joya
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipurparulsinha
 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Servicevidya singh
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...Garima Khatri
 
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls ServiceMiss joya
 
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore EscortsCall Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escortsvidya singh
 
Call Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night EnjoyCall Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night Enjoybabeytanya
 
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on DeliveryCall Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Deliverynehamumbai
 
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls ServiceMiss joya
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableNehru place Escorts
 
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...astropune
 

Recently uploaded (20)

Aspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliAspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas Ali
 
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomLucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
 
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort ServiceCall Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
 
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
 
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
 
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
Book Paid Powai Call Girls Mumbai 𖠋 9930245274 𖠋Low Budget Full Independent H...
 
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual NeedsBangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
 
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
 
Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...
Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...
Call Girls Service Pune Vaishnavi 9907093804 Short 1500 Night 6000 Best call ...
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
 
Escort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCR
Escort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCREscort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCR
Escort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCR
 
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls Service
 
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore EscortsCall Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
 
Call Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night EnjoyCall Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night Enjoy
 
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on DeliveryCall Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
 
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls Service
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
 
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
 

Dedication-Clemmensen

  • 1. Peter Clemmensen, Henning Kelbæk, Anne Kaltoft, Steffen Helqvist, Jens Flensted Lassen, Lene Kløvgaard, Christian J Terkelsen, Hans Henrik Tilsted, Thomas Engstrøm, Lars R Krusell, Evald H. Christiansen, Kari Saunamäki, Erik Jørgensen, Hans E. Bøtker, Jan Ravkilde, Klaus F Kofoed, Lars Køber, Leif Thuesen Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-elevation myocardial infarction 3 year follow-up of the randomised DEDICATION trial Copenhagen University Hospital Rigshospitalet Aarhus University Hospital Skejby Denmark
  • 2.
  • 3.
  • 4. Drug-Eluting vs Bare-Metal Stent Implantation during Primary PCI Previous published studies with ≥ 150 patients Study STRATEGY TYPHOON PASSION SESAMI n 175 712 619 320 FU 133 170 - 166 DES/BMS 18/32 7/14 9/13 7/17 DES/BMS 8/28 7/20 - 9/21 endpoint MACCE TVF MACE RS p 0.001 0.004 0.09 0.03 Invasive Primary RS,% MACE,%
  • 5.
  • 6. STEMI n=626 Randomization + Distal Protection - Distal Protection Bare Metal Stent MACE Angiography - QCA / MACE 1 month 15 months Bare Metal Stent Drug Eluting Stent Drug Eluting Stent Flow chart Post Procedure Angiography - QCA MACE MACE 8 months 3 years
  • 7. STEMI n=626 Randomization + Distal Protection - Distal Protection Bare Metal Stent MACE Angiography - QCA / MACE 1 month 15 months Bare Metal Stent Drug Eluting Stent Drug Eluting Stent Flow chart Post Procedure Angiography - QCA MACE MACE 8 months 3 years
  • 8.
  • 9.
  • 10.
  • 11.
  • 12. STEMI - PPCI n: 626 Randomization Drug Eluting Stent n: 313 Bare Metal Stent n: 313 Number of Patients
  • 13. Baseline clinical characteristics DES n=313 BMS n=313 p 0.41 0.93 0.30 0.67 0.54 0.88 0.87 0.45 0.20 0.56 0.69 0.63 63 73.5 11.5 34.0 21.4 54.7 38.2 0.47 7.1 5.4 200 25 62 72.8 9.3 32.3 18.7 52.7 37.3 0.48 6.1 4.5 197 25 Age (years) Male gender (%) Diabetes Mellitus (%) Hypertension (%) Hyperlipidemia (%) Current smoker (%) Family history of CAD (%) Left ventricular ejection fraction Previous myocardial infarction (%) Previous PCI / CABG (%) Symptom onset to arrival, min Door-to-balloon, min
  • 14. Baseline lesion characteristics 0.27 DES n=313 BMS n=313 p 0.57 0.47 38 14 48 61 29 10 70 30 44 11 45 65 25 10 65 35 Infarct related coronary artery (%) LAD CX RCA Number of diseased vessel (%) 1 vessel disease 2 vessel disease 3 vessel disease Baseline TIMI flow TIMI 0-1 TIMI 2-3
  • 15. Procedural results DES n=313 BMS n=313 p 0.21 0.33 0.38 0.29 0.52 0.13 0.86 0.20 1.00 0.73 95 72 42 98 1.3 21.0 3.53 16.3 90 99 97 74 40 99 1.3 22.2 3.54 16.7 90 98 Use of GP IIb/IIIa inhibitor, % Visible thrombus,% Filterwire used, % Stent implanted, % Number of stents per lesion Stented length, mm Stent diameter, mm Max deployment pressure, mm Hg TIMI III post procedure Procedural success, %
  • 16. P=0.084 P=0.013 P=0.58 P=0.45 P<0.001 P<0.001 P=0.64 P=0.024 MACE during 3 years
  • 17. 0 200 400 600 800 1000 1200 P=0.028 DES BMS 100 80 60 40 Freedom from MACE Freedom from MACE Days
  • 18. 0 200 400 600 800 1000 1200 P=0.059 DES BMS 100 80 60 40 Freedom from all-cause mortality (%) Freedom from all-cause mortality Days
  • 19. 0 200 400 600 800 1000 1200 P=0.008 DES BMS 100 80 60 40 Freedom from cardiac mortality (%) Freedom from cardiac mortality Days
  • 20. 10 8 6 4 2 0 P=0.511 DES BMS Cumulative incidence (%) 0 200 400 600 800 1000 1200 Any stent thrombosis Days
  • 21. 10 8 6 4 2 0 P=0.296 DES BMS Cumulative incidence (%) 0 200 400 600 800 1000 1200 Definite stent thrombosis Days
  • 22. 0 0.5 1.0 0.5 2.0 no DM 561 11.3 17.7 DM 65 13.8 22.2 Female 168 10.6 24.1 Male 458 11.8 16.1 Age  63 311 13.7 17.1 Age < 63 315 9.4 19.4 All 626 11.5 18.2 Group n DES BMS DES better BMS better Odds Ratio (95% CI) Rate of MACE (%) Subgroup analysis CX / RCA 368 9.4 16.4 LAD 258 14.8 20.6 Stent length  18 mm 310 9.5 17.9 Stent length > 18 mm 309 12.9 17.8 No visible thrombus 168 11.1 24.1 Visible thrombus 458 11.6 15.9 Ref D  3.1 mm 299 12.0 20.8 Ref D > 3.1 mm 317 9.6 15.6
  • 23. 0 0.5 1.0 0.5 2.0 no DM 561 11.3 17.7 DM 65 13.8 22.2 Female 168 10.6 24.1 Male 458 11.8 16.1 Age  63 311 13.7 17.1 Age < 63 315 9.4 19.4 All 626 11.5 18.2 Group n DES BMS DES better BMS better Odds Ratio (95% CI) Rate of MACE (%) Subgroup analysis CX / RCA 368 9.4 16.4 LAD 258 14.8 20.6 Stent length  18 mm 310 9.5 17.9 Stent length > 18 mm 309 12.9 17.8 No visible thrombus 168 11.1 24.1 Visible thrombus 458 11.6 15.9 Ref D  3.1 mm 299 12.0 20.8 Ref D > 3.1 mm 317 9.6 15.6
  • 24. 0 0.5 1.0 0.5 2.0 no DM 561 11.3 17.7 DM 65 13.8 22.2 Female 168 10.6 24.1 Male 458 11.8 16.1 Age  63 311 13.7 17.1 Age < 63 315 9.4 19.4 All 626 11.5 18.2 Group n DES BMS DES better BMS better Odds Ratio (95% CI) Rate of MACE (%) Subgroup analysis CX / RCA 368 9.4 16.4 LAD 258 14.8 20.6 Stent length  18 mm 310 9.5 17.9 Stent length > 18 mm 309 12.9 17.8 No visible thrombus 168 11.1 24.1 Visible thrombus 458 11.6 15.9 Ref D  3.1 mm 299 12.0 20.8 Ref D > 3.1 mm 317 9.6 15.6
  • 25. 0 0.5 1.0 0.5 2.0 no DM 561 11.3 17.7 DM 65 13.8 22.2 Female 168 10.6 24.1 Male 458 11.8 16.1 Age  63 311 13.7 17.1 Age < 63 315 9.4 19.4 All 626 11.5 18.2 Group n DES BMS DES better BMS better Odds Ratio (95% CI) Rate of MACE (%) Subgroup analysis CX / RCA 368 9.4 16.4 LAD 258 14.8 20.6 Stent length  18 mm 310 9.5 17.9 Stent length > 18 mm 309 12.9 17.8 No visible thrombus 168 11.1 24.1 Visible thrombus 458 11.6 15.9 Ref D  3.1 mm 299 12.0 20.8 Ref D > 3.1 mm 317 9.6 15.6
  • 26.